Showing results (1221-1230 of 1,328) with videos related to

Sort By:
Pageof 133
Implementation Science : IS|June 27, 2013
Designing a valid randomized pragmatic primary care implementation trial: the my own health report (MOHR) projectAlex H Krist, Beth A Glenn, Russell E Glasgow, et al.
Plos One|November 28, 2012
The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanismXin Zheng, Natalia B Rumie Vittar, Xiaohong Gai, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
An Intercompany Perspective on Biopharmaceutical Drug Product Robustness StudiesSorina Morar-Mitrica, Monica L Adams, George Crotts, et al.
Cancer Cell|May 27, 2014
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinomaAndrew D Rhim, Paul E Oberstein, Dafydd H Thomas, et al.
JMIR Formative Research|February 12, 2025
Increasing COVID-19 Testing and Vaccination Uptake in the Take Care Texas Community-Based Randomized Trial: Adaptive Geospatial AnalysisKehe Zhang, Jocelyn V Hunyadi, Marcia C de Oliveira Otto, et al.
Health Education Research|July 8, 2020
Adaptation of public health initiatives: expert views on current guidance and opportunities to advance their application and benefitSze Lin Yoong, Katarzyna Bolsewicz, Alice Grady, et al.
The Journal of Biological Chemistry|January 29, 2020
The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complexRyan M Carr, Paola A Romecin Duran, Ezequiel J Tolosa, et al.
BMC Biology|April 13, 2019
Derivation of adult canine intestinal organoids for translational research in gastroenterologyLawrance Chandra, Dana C Borcherding, Dawn Kingsbury, et al.
The Journal of Biological Chemistry|April 6, 2021
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibitionIsaac P Horn, David L Marks, Amanda N Koenig, et al.
Pageof 133